16436588 |
Potent inhibition of platelet-derived growth factor-induced responses in vascular smooth muscle cells by BMS-354825 (dasatinib)
Chen, Z,
Lee, FY,
Bhalla, KN,
Wu, J
|
Mol. Pharmacol. |
2006 |
21251937 |
Inhibition of PDGF, TGF-β, and Abl signaling and reduction of liver fibrosis by the small molecule Bcr-Abl tyrosine kinase antagonist Nilotinib
Liu, Y,
Wang, Z,
Kwong, SQ,
Lui, ELH,
Friedman, SL,
Li, FR,
Lam, RWC,
Zhang, GC,
Zhang, H,
Ye, T
|
J. Hepatol. |
2011 |
29408302 |
The role of small molecule platelet-derived growth factor receptor (PDGFR) inhibitors in the treatment of neoplastic disorders
Roskoski, R
|
Pharmacol. Res. |
2018 |
23583652 |
Pazopanib inhibits the activation of PDGFRβ-expressing astrocytes in the brain metastatic microenvironment of breast cancer cells
Gril, B,
Palmieri, D,
Qian, Y,
Anwar, T,
Liewehr, DJ,
Steinberg, SM,
Andreu, Z,
Masana, D,
Fernández, P,
Steeg, PS,
Vidal-Vanaclocha, F
|
Am. J. Pathol. |
2013 |
9739761 |
Signal transduction via platelet-derived growth factor receptors
Heldin, CH,
Ostman, A,
Rönnstrand, L
|
Biochim Biophys Acta |
1998 |
17604334 |
Platelet-derived growth factor receptor-alpha: a novel therapeutic target in human hepatocellular cancer
Stock, P,
Monga, D,
Tan, X,
Micsenyi, A,
Loizos, N,
Monga, SP
|
Mol. Cancer Ther. |
2007 |
18559524 |
BIBF 1120: triple angiokinase inhibitor with sustained receptor blockade and good antitumor efficacy
Hilberg, F,
Roth, GJ,
Krssak, M,
Kautschitsch, S,
Sommergruber, W,
Tontsch-Grunt, U,
Garin-Chesa, P,
Bader, G,
Zoephel, A,
Quant, J,
Heckel, A,
Rettig, WJ
|
Cancer Res. |
2008 |
17943726 |
E7080, a novel inhibitor that targets multiple kinases, has potent antitumor activities against stem cell factor producing human small cell lung cancer H146, based on angiogenesis inhibition
Matsui, J,
Yamamoto, Y,
Funahashi, Y,
Tsuruoka, A,
Watanabe, T,
Wakabayashi, T,
Uenaka, T,
Asada, M
|
Int J Cancer |
2008 |
25328409 |
Crenolanib, a PDGFR inhibitor, suppresses lung cancer cell proliferation and inhibits tumor growth in vivo
Wang, P,
Song, L,
Ge, H,
Jin, P,
Jiang, Y,
Hu, W,
Geng, N
|
Onco Targets Ther |
2014 |
16331269 |
Autocrine activation of PDGFRalpha promotes the progression of ovarian cancer
Matei, D,
Emerson, RE,
Lai, YC,
Baldridge, LA,
Rao, J,
Yiannoutsos, C,
Donner, DD
|
Oncogene |
2006 |
12369853 |
BAY 43-9006: preclinical data
Wilhelm, S,
Chien, DS
|
Curr. Pharm. Des. |
2002 |
15615512 |
Discovery of N-(2-chloro-6-methyl- phenyl)-2-(6-(4-(2-hydroxyethyl)- piperazin-1-yl)-2-methylpyrimidin-4- ylamino)thiazole-5-carboxamide (BMS-354825), a dual Src/Abl kinase inhibitor with potent antitumor activity in preclinical assays
Lombardo, LJ,
Lee, FY,
Chen, P,
Norris, D,
Barrish, JC,
Behnia, K,
Castaneda, S,
Cornelius, LA,
Das, J,
Doweyko, AM,
Fairchild, C,
Hunt, JT,
Inigo, I,
Johnston, K,
Kamath, A,
Kan, D,
Klei, H,
Marathe, P,
Pang, S,
Peterson, R,
Pitt, S,
Schieven, GL,
Schmidt, RJ,
Tokarski, J,
Wen, ML,
Wityak, J,
Borzilleri, RM
|
J. Med. Chem. |
2004 |
12538485 |
In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: determination of a pharmacokinetic/pharmacodynamic relationship
Mendel, DB,
Laird, AD,
Xin, X,
Louie, SG,
Christensen, JG,
Li, G,
Schreck, RE,
Abrams, TJ,
Ngai, TJ,
Lee, LB,
Murray, LJ,
Carver, J,
Chan, E,
Moss, KG,
Haznedar, JO,
Sukbuntherng, J,
Blake, RA,
Sun, L,
Tang, C,
Miller, T,
Shirazian, S,
McMahon, G,
Cherrington, JM
|
Clin. Cancer Res. |
2003 |
25597754 |
The FLT3 and PDGFR inhibitor crenolanib is a substrate of the multidrug resistance protein ABCB1 but does not inhibit transport function at pharmacologically relevant concentrations
Mathias, TJ,
Natarajan, K,
Shukla, S,
Doshi, KA,
Singh, ZN,
Ambudkar, SV,
Baer, MR
|
Invest New Drugs |
2015 |
22933705 |
Stromal platelet-derived growth factor receptor α (PDGFRα) provides a therapeutic target independent of tumor cell PDGFRα expression in lung cancer xenografts
Gerber, DE,
Gupta, P,
Dellinger, MT,
Toombs, JE,
Peyton, M,
Duignan, I,
Malaby, J,
Bailey, T,
Burns, C,
Brekken, RA,
Loizos, N
|
Mol. Cancer Ther. |
2012 |
29263244 |
Triple Angiokinase Inhibitor Nintedanib Directly Inhibits Tumor Cell Growth and Induces Tumor Shrinkage via Blocking Oncogenic Receptor Tyrosine Kinases
Hilberg, F,
Tontsch-Grunt, U,
Baum, A,
Le, AT,
Doebele, RC,
Lieb, S,
Gianni, D,
Voss, T,
Garin-Chesa, P,
Haslinger, C,
Kraut, N
|
J. Pharmacol. Exp. Ther. |
2018 |
17367763 |
Sunitinib: a VEGF and PDGF receptor protein kinase and angiogenesis inhibitor
Roskoski, R
|
Biochem. Biophys. Res. Commun. |
2007 |
28435517 |
Inhibition of the platelet-derived growth factor receptor beta (PDGFRB) using gene silencing, crenolanib besylate, or imatinib mesylate hampers the malignant phenotype of mesothelioma cell lines
Melaiu, O,
Catalano, C,
De Santi, C,
Cipollini, M,
Figlioli, G,
Pellè, L,
Barone, E,
Evangelista, M,
Guazzelli, A,
Boldrini, L,
Sensi, E,
Bonotti, A,
Foddis, R,
Cristaudo, A,
Mutti, L,
Fontanini, G,
Gemignani, F,
Landi, S
|
Genes Cancer |
2017 |
16474853 |
Preclinical and clinical development of the oral multikinase inhibitor sorafenib in cancer treatment
Strumberg, D
|
Drugs Today |
2005 |
20813817 |
Targeting the {alpha} receptor for platelet-derived growth factor as a primary or combination therapy in a preclinical model of prostate cancer skeletal metastasis
Russell, MR,
Liu, Q,
Fatatis, A
|
Clin. Cancer Res. |
2010 |